Search
for
Sort by
Research 421–450 of 559
- Enhanced remyelination during late pregnancy: involvement of the GABAergic system
- The medusa head: Dermoscopic diagnosis of woolly hair syndrome
- Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
- Biotin Is Required for the Zinc Homeostasis in the Skin
- EBS in Children with De Novo Pathogenic Variants Disturbing Krt14
- Photobiomodulation devices for hair regrowth and wound healing: a therapy full of promise but a literature full of confusion
- Polycystic ovarian syndrome: current understanding of pathogenesis, diagnosis and treatment
- Stem cells in embryonic skin development
- A Novel Approach Against Male Pattern Hair Loss With Topical Dimethylglycine Sodium Salt (DMG‐Na) and Caffeine: Efficacy of a 24‐Week, Double‐Blind, Randomized, Placebo‐Controlled Trial
- <i>Pseudomonas aeruginosa</i> heme metabolites biliverdin IXβ and IXδ are integral to lifestyle adaptations associated with chronic infection
- A new START
- Efficacy of Platelet-Rich Plasma versus Mesotherapy with Recombinant Growth Factors and Stem Cell-Conditioned Media in Androgenetic Alopecia: A Retrospective Study
- Imaging to study solid tumour origin and progression: lessons from research and clinical oncology
- Heavy metals in biological samples of cancer patients: a systematic literature review
- Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves
- Epigenetic age estimation in saliva and in buccal cells
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- A COMPREHENSIVE REVIEW ON PHARMACOLOGICAL POTENTIALS OF CAFFEINE
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Montagna Symposium 2013—Light and Skin: How Light Sustains, Damages, Treats, Images and Modifies Skin Biology
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- The effects of phosphodiesterase 3 (PDE3) inhibitor on hair follicle cell viability and hair growth
- 570 Targeting phosphodiesterase 8A (PDE8A) to boost adipogenesis and hair regeneration